iiinova — where your digital self keeps evolving

Reposted by Dr. Ferrandiz

Retro Blast 👻 @retroblastpod.com · 03/09/2026

A retro game is a brand new game if you've never played it..

An image of Willem Dafoe in a large coat that I've edited with him holding a dreamcast controller by the cable, sonic adventure and power stone posters behind him, and a large crt tv stand with gameplay on the screen and consoles inside the stand

773079507

Reposted by Dr. Ferrandiz

Rheum Cat @rheumcat.bsky.social · 02/09/2026

Thank you @uwrheum.bsky.social family for an amazing trip 🏔️

Renato and me outside UW after accidentally walking in the wrong direction for no reason for over a mile even though I walked the intended route multiple times for a year

Me and Namrata hugging; I am wearing a lot of beige and she is in colorful florals as reflect our inner characters

Me and Jenna in her kitchen. She does not look like she’s been planning a garden party and corralling kids all afternoon

1161

Dr. Ferrandiz @renatoferrandiz.bsky.social · 29/07/2026

Happy Independence Peru day!🇵🇪

000

Dr. Ferrandiz @renatoferrandiz.bsky.social · 25/04/2026

Best friends since forever(11 months) #Bond

010

Reposted by Dr. Ferrandiz

Rheum Cat @rheumcat.bsky.social · 11/04/2026

This guy just got his first grant! 👏 @nasingh.bsky.social @restovall.bsky.social

0102

Dr. Ferrandiz @renatoferrandiz.bsky.social · 20/11/2025

ANCA vasculitis awareness day at the VA(?)

000

Dr. Ferrandiz @renatoferrandiz.bsky.social · 11/11/2025

After a long day at work, finding my #ACR25 #RheumCat sticker waiting for me brought a smile. Dr. @rheumcat.bsky.social makes Rheumatology easier to navigate through her dedication, motivation, and genuine care for her trainees. Her example inspires me every day, and I am forever grateful. 💙🐈‍⬛

010

Reposted by Dr. Ferrandiz

Alison Bays, MD (she/her) @alisonbays.bsky.social · 26/10/2025

Poster: subcutaneous tocilizumab may be more effective in #GCA than IV. So unfortunate that many of our seniors can only get IV due to health insurance 😢 #ACR25

012

Reposted by Dr. Ferrandiz

Alison Bays, MD (she/her) @alisonbays.bsky.social · 26/10/2025

I did comb through our #GCA Fast Track Clinic and also didn’t find seasonal variation but agree, sure feels like it is seasonal at times! #ACR25

012

Reposted by Dr. Ferrandiz

Alison Bays, MD (she/her) @alisonbays.bsky.social · 26/10/2025

Unfortunate information on #ANCA vasculitis and #GCA clinical trials showing poor representation of patients and a low number even reporting race. We need to do better. #ACR25

011

Reposted by Dr. Ferrandiz

Rheum Cat @rheumcat.bsky.social · 02/07/2025

Congrats to @renatoferrandiz.bsky.social on the publication of the SPARTAN Clinical Year in Review He transformed the talk that I gave into digestible figures and text rdcu.be/euouC cc @ruthjeannapier.bsky.social @mohamadbittarmd.bsky.social @spondymd.bsky.social @restovall.bsky.social

rdcu.be

Spondyloarthritis Research and Treatment Network (SPARTAN) Clinical and Imaging Year in Review 2024

061

Reposted by Dr. Ferrandiz

Rheum Cat @rheumcat.bsky.social · 10/05/2025

Our work was cited in terms of diagnostic delay in axial spondyloarthritis @renatoferrandiz.bsky.social @spondymd.bsky.social

Two studies about diagnostic delay in axial spondyloarthritis: Magrey et al and Ferrandiz et al

Dr Sibel Aydin presenting at the SPARTAN annual meeting

3276

Reposted by Dr. Ferrandiz

The Journal of Rheumatology @jrheumatol.bsky.social · 25/04/2025

Editor's Picks Spotlight Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil @renatoferrandiz.bsky.social @rheumcat.bsky.social @spondymd.bsky.social 📖 doi.org/10.3899/jrhe... 📽️ youtu.be/jXAe-dlbxsc

youtu.be

Editor's Picks Spotlight: Disparities in Time to Diagnosis of r-axSpA

YouTube video by The Journal of Rheumatology

033

Reposted by Dr. Ferrandiz

The Journal of Rheumatology @jrheumatol.bsky.social · 03/04/2025

Editorial Disparities in Diagnosis: A Call for Equity in Radiographic Axial Spondyloarthritis Care 📖 doi.org/10.3899/jrhe... @umasschan.bsky.social #socialdisparities #radiographic #axSpA

131

Reposted by Dr. Ferrandiz

NANCY COMICS BY ERNIE BUSHMILLER @nancycomics.bsky.social · 04/04/2025

Nancy By Ernie Bushmiller April 4,1950

NANCY BY ERNIE BUSHMILLER

SLUGGO--WHY ARE YOU
WEARING THAT OUTFIT?

I'M GONNA MARCH IN A PARADE
TODAY

HOW DO YOU KEEP THAT BIG HAT FROM FALLING OFF?

( SLUGGO HAS A PLUMBER’S HELPER STUCK TO HIS HEAD)

1871437

Reposted by Dr. Ferrandiz

The Journal of Rheumatology @jrheumatol.bsky.social · 03/04/2025

Research Article Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis 📖 www.jrheum.org/cgi/content/... @renatoferrandiz.bsky.social @rheumcat.bsky.social @spondymd.bsky.social #socialdisparities #radiographic #axSpA

011

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T3f: #NephJC Obinutuzumab is currently tested as an add-on to lower steroids + high-dose MMF in LN. (Although, has anyone seen some palpable number on cortico total dose) Key question: Can it reduce background immunosuppression?

031

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T3e: And their results: their definitions of CRR, PRR vary #NephJC Any thoughts?

164

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T3d: Here are the trials with cell B blockers (yeah, induction, refractory LN, or whatever). Any notable differences in their design? #nephjc

21310

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T3b: Obinutuzumab achieved sustained B-cell depletion (CD19+ <10/µL) in 95% of patients through week 76, outperforming Rituximab (~80% at week 52, LUNAR trial). pubmed.ncbi.nlm.nih.... Obvious question: why REGENCY was positive and LUNAR negative? #nephJC

365

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T3a: Short recap: #NephJC 🔹REGENCY trial confirms type 2 anti-CD20 efficacy in active lupus nephritis. 🔹Obinutuzumab + standard therapy improved renal response vs. placebo, aligning with NOBILITY trial findings

173

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T0l: #NephJC Type II anti-CD20 mAbs (e.g., obinutuzumab) induce stronger B-cell cytotoxicity and enhanced phagocytosis, resulting in deeper and more sustained depletion, including in tissue-resident B-cell niches

3157

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T0k: #NephJC Based on BLISS-LN findings, belimumab is recommended by @kdigo.org as 1st line therapy www.nephjc.com/news/...

292

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T0b: About 10–25% of patients will develop chronic kidney disease (CKD), and it has been described mortality of 10–20% at 10yrs #NephJC 🔸Studies= heterogeneous 🔸Demographics associated with worse renal outcomes: age (y<40 at the time of LN diagnosis) and Hispanic ethnicity pubmed.ncbi.nlm.nih....

162

Reposted by Dr. Ferrandiz

Nephrology Journal Club @nephjc.bsky.social · 12/03/2025

T0d: #NephJC A recent #kireports electronic cohort-based study showed that compared with other primary GNs, in LN there is a slightly ⬇️risk of KRT. With LN-CKD 👉 higher risk of 🔸MACE HR 1.63 (95% CI, 1.32–2.02) 🔸all-cause mortality 1.65 (1.31–2.08) www.kireports.org/ar...

052

Reposted by Dr. Ferrandiz

Rheum Cat @rheumcat.bsky.social · 08/03/2025

Second positive thing: Mentee @renatoferrandiz.bsky.social is being interviewed by a rheumatology journal for the study he led with us on disparities affecting time to diagnosis for individuals living with axial spondyloarthritis Important DEI work, right there

072

Dr. Ferrandiz @renatoferrandiz.bsky.social · 07/02/2025

A very controversial case that may lead to a great discussion! Is #Hydralazine that bad? See you at the #ACP in #NOLA. #lupus

020

Dr. Ferrandiz @renatoferrandiz.bsky.social · 13/01/2025

Thrilled to begin my Rheumatology fellowship this year, with a focus on tackling and raising awareness of social disparities! Lets start with r-axSpA! #RheumFellowship #AxSpA #HealthEquity

191

Dr. Ferrandiz @renatoferrandiz.bsky.social · 31/12/2024

Before the year ends, I am thankful for the opportunity of publishing this work. I will do my best this 2025 as well! @spondymd.bsky.social @rheumcat.bsky.social

071